Research ArticleAtherosclerosis

Long noncoding RNA SNHG12 integrates a DNA-PK–mediated DNA damage response and vascular senescence

See allHide authors and affiliations

Science Translational Medicine  19 Feb 2020:
Vol. 12, Issue 531, eaaw1868
DOI: 10.1126/scitranslmed.aaw1868

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

A senescent lnc to atherosclerosis

DNA damage and senescence are thought to enhance atherosclerotic lesion formation, although how this happens is unclear. Haemmig et al. identified an endothelial-enriched long noncoding RNA (lncRNA) as a DNA-dependent protein kinase (DNA-PK)–dependent regulator of vascular DNA damage and cellular senescence. Small nucleolar host gene-12 (SNHG12) was down-regulated in mouse, pig, and human atherosclerotic arteries and correlated with DNA damage and senescence. Endothelial Snhg12 knockdown exacerbated vascular cellular senescence and lesion formation in mouse models of atherosclerosis. Both nicotinamide riboside administration and intravenous delivery of Snhg12 rescued disease progression in vivo, suggesting potential to combat atherosclerosis by targeting a mechanism of vascular senescence.


Long noncoding RNAs (lncRNAs) are emerging regulators of biological processes in the vessel wall; however, their role in atherosclerosis remains poorly defined. We used RNA sequencing to profile lncRNAs derived specifically from the aortic intima of Ldlr−/− mice on a high-cholesterol diet during lesion progression and regression phases. We found that the evolutionarily conserved lncRNA small nucleolar host gene-12 (SNHG12) is highly expressed in the vascular endothelium and decreases during lesion progression. SNHG12 knockdown accelerated atherosclerotic lesion formation by 2.4-fold in Ldlr−/− mice by increased DNA damage and senescence in the vascular endothelium, independent of effects on lipid profile or vessel wall inflammation. Conversely, intravenous delivery of SNHG12 protected the tunica intima from DNA damage and atherosclerosis. LncRNA pulldown in combination with liquid chromatography–tandem mass spectrometry (LC-MS/MS) analysis showed that SNHG12 interacted with DNA-dependent protein kinase (DNA-PK), an important regulator of the DNA damage response. The absence of SNHG12 reduced the DNA-PK interaction with its binding partners Ku70 and Ku80, abrogating DNA damage repair. Moreover, the anti-DNA damage agent nicotinamide riboside (NR), a clinical-grade small-molecule activator of NAD+, fully rescued the increases in lesional DNA damage, senescence, and atherosclerosis mediated by SNHG12 knockdown. SNHG12 expression was also reduced in pig and human atherosclerotic specimens and correlated inversely with DNA damage and senescent markers. These findings reveal a role for this lncRNA in regulating DNA damage repair in the vessel wall and may have implications for chronic vascular disease states and aging.

View Full Text

Stay Connected to Science Translational Medicine